287
Views
7
CrossRef citations to date
0
Altmetric
NOSE/SINUS

Outcomes of surgically treated rhinogenic optic neuropathy

, , , , &
Pages 833-839 | Received 15 Dec 2010, Accepted 20 Jan 2011, Published online: 05 Apr 2011

References

  • Fujimoto N, Adachi-Usami E, Saito E, Nagata H. Optic nerve blindness due to paranasal sinus disease. Ophthalmologica 1999;213:262–4.
  • Lee LA, Huang CC, Lee TJ. Prolonged visual disturbance secondary to isolated sphenoid sinus disease. Laryngoscope 2004;114:986–90.
  • Loo JL, Looi AL, Seah LL. Visual outcomes in patients with paranasal mucoceles. Ophthal Plast Reconstr Surg 2009;25:126–9.
  • Moriyama H, Hesaka H, Tachibana T, Honda Y. Mucoceles of ethmoid and sphenoid sinus with visual disturbance. Arch Otolaryngol Head Neck Surg 1992;118:142–6.
  • Yoon TM, Kim K, Lim SC. Visual outcome after endoscopic decompression surgery for sphenoid sinus disease: how we do it. Clin Otolaryngol 2008;33:480–4.
  • Yumoto E, Hyodo M, Kawakita S, Aibara R. Effect of sinus surgery on visual disturbance caused by spheno-ethmoid mucoceles. Am J Rhinol 1997;11:337–43.
  • Ikeda K, Kondo Y, Sunose H, Hirano K, Oshima T, Shimomura A, Subjective and objective evaluation in endoscopic sinus surgery. Am J Rhinol 1996;10:217–20.
  • Bulters DO, Shenouda E, Evans BT, Mathad N, Lang DA. Visual recovery following optic nerve decompression for chronic compressive neuropathy. Acta Neurochir (Wien) 2009;151:325–34.
  • Lovie-Kitchin JE. Validity and reliability of visual acuity measurements. Ophthalmic Physiol Opt 1988;8:363–70.
  • Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities “hand motion” and “counting fingers” can be quantified with the freiburg visual acuity test. Invest Ophthalmol Vis Sci 2006;47:1236–40.
  • Grover S, Fishman GA, Anderson RJ, Tozatti MS, Heckenlively JR, Weleber RG, Visual acuity impairment in patients with retinitis pigmentosa at age 45 years or older. Ophthalmology 1999;106:1780–5.
  • Beck RW, Cleary PA, Anderson MM, Keltner JL, Shults WT, Kaufman DI, A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 1992;326:581–8.
  • Levin LA, Beck RW, Joseph MP, Seiff S, Kraker R. The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthalmology 1999;106:1268–77.
  • Miller DM, Weinstock-Guttman B, Béhoux F, Lee JC, Beck G, Block V, A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations. Mult Scler 2000;6:267–73.
  • Dutt M, Tabuena P, Ventura E, Rostami A, Shindler KS. Timing of corticosteroid therapy is critical to prevent retinal ganglion cell loss in experimental optic neuritis. Invest Ophthalmol Vis Sci 2010;51:1439–45.
  • Brechner RJ, Cowie CC, Howie LJ, Herman WH, Will JC, Harris MI. Ophthalmic examination among adults with diagnosed diabetes mellitus. JAMA 1993;270:1714–18.
  • Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36:150–4.
  • Kamijo M, Cherian PV, Sima AA. The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W-rat. Diabetologia 1993;36:893–8.
  • Duby JJ, Campbell RK, Setter SM, White JR, Rasmussen KA. Diabetic neuropathy: an intensive review. Am J Health Syst Pharm 2004;61:160–73; quiz 175–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.